Error: Could not add to watchlist. X

Orexigen Therapeutics Inc

+ Watchlist
OREX:US
NASDAQ GS
5.01
USD
0.17
3.41%
As of 20:10:00 ET on 06/03/2015.
Open
4.85
Day Range
4.81 - 5.07
Volume
2,518,862
Previous Close
4.85
52Wk Range
3.11 - 9.37
1 Yr Return
-19.45%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.26
Market Cap (m USD)
627.352
Shares Outstanding (m)
125.220
Price/Sales (TTM)
10.42
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma
Profile
Orexigen Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of the central nervous system (CNS) disorders with an initial focus on obesity.
ADDRESS
3344 N. Torrey Pines Court
Suite 200
La Jolla, CA 92037
United States
PHONE
1-858-875-8600
  • Michael A Narachi "Mike"
    President/CEO
  • Tom Cannell
    Chief Commercial Officer
  • Joseph P Hagan "Jay"
    Chief Bus & Financial Officer
  • Heather D Turner
    Senior VP/Secretary/Gen Cnsl
  • Preston S Klassen
    Exec VP:Global Development
Show More